-
Carrier
Hamilton Sundstrand
Otis
Pratt & Whitney
Sikorsky
UTC Fire & Security
UTC Power
-
Carrier
-
Hamilton Sundstrand
-
Otis
-
Pratt & Whitney
-
Sikorsky
-
UTC Fire & Security
-
UTC Power
Jean-Pierre Garnier, Retired CEO, GlaxoSmithKline
JEAN-PIERRE GARNIER, Ph.D., has been Chairman of the Board of Directors of Actelion Ltd (biopharmaceuticals) since September 2011. He previously served as Chief Executive Officer of Pierre Fabre SA (pharmaceuticals and cosmetics) from 2008 to 2010 and Chief Executive Officer and Executive Member of the Board of Directors of GlaxoSmithKline plc from 2000 to 2008. Dr. Garnier served as Chief Executive Officer of SmithKline Beecham plc in 2000 and as Chief Operating Officer and Executive Member of the Board of Directors of SmithKline Beecham plc from 1996 to 2000. Dr. Garnier is also a director of Renault S.A. and Cerenis Therapeutics. In 2009, he was made a Knight Commander of the British Empire. In 2007, he was promoted from Chevalier to Officier de la Légion d’Honneur of France. In 2006, he was named to the global list of top 20 CEOs by the Best Practice Institute. He was previously a board member of the Stanford Advisory Council on Interdisciplinary Biosciences, Cornell-Weill Medical College, and the Dubai International Capital Advisory Board. He is currently Chairman of NormOxys (biotechnology development), an operating partner at Advent International (global private equity) and a member of the Board of Trustees of the Paul Newman Foundation. Dr. Garnier is 63 and has been a UTC director since 1997.
